• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    1/18/23 1:25:40 PM ET
    $ACHR
    $AGRI
    $ANY
    $ARVL
    Aerospace
    Industrials
    Metal Fabrications
    Industrials
    Get the next $ACHR alert in real time by email

    Gainers

    • Ontrak, Inc. (NASDAQ:OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
    • Aceragen Inc. (NASDAQ:ACGN) shares gained 61.3% to $11.65.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) gained 44% to $7.07 after the company on Tuesday announced a strategic collaboration to advance gamma-delta T cells in oncology.
    • Energy Vault Holdings, Inc. (NYSE:NRGV) shares gained 42.4% to $5.08 after the company updated Q4 and FY22 expected revenue results.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 34.6% to $4.66.
    • Sigilon Therapeutics, Inc. (NASDAQ:SGTX) climbed 32.8% to $0.5488 after Canaccord Genuity initiated coverage on the stock with a Buy rating and a $6 price target.
    • Digihost Technology Inc. (NASDAQ:DGHI) rose 32.2% to $1.39.
    • Atlas Lithium Corporation (NASDAQ:ATLX) gained 28.5% to $10.93 after the company announced it signed a MOU with Mitsui & Co. with respect to Mitsui's potential interest in acquiring the right to purchase Atlas Lithium's future lithium concentrate production.
    • Magic Empire Global Limited (NASDAQ:MEGL) climbed 27% to $2.6650.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 25.4% to $0.5940 after the company announced strategic agreement with the City of Huanggang and signed a new shareholder agreement with FF Global Partners.
    • Tricida, Inc. (NASDAQ:TCDA) gained 23.1% to $0.1632.
    • AMTD Digital Inc. (NYSE:HKD) surged 22.2% to $13.10.
    • Nuvve Holding Corp. (NASDAQ:NVVE) jumped 19.8% to $1.45.
    • Siyata Mobile Inc. (NASDAQ:SYTA) rose 19.8% to $0.2756 after the company announced it received follow-on orders for its UV350 device from a leading Saudi Arabian cellular carrier.
    • Archer Aviation Inc. (NYSE:ACHR) gained 19.2% to $3.0750 following Form 4 filings which showed insider buys from director and CEO Adam D Goldstein and director Fred M Diaz.
    • RenovoRx, Inc. (NASDAQ:RNXT) jumped 19% to $4.70 after the company announced initial results from a pharmacokinetic substudy within the Phase 3 TIGeR-PaC clinical trial to be presented at the 2023 ASCO Gastrointestinal Cancers Symposium between January 19-21.
    • GSE Systems, Inc. (NASDAQ:GVP) gained 18.1% to $0.85. GSE announced renewed 5-year contract with additional options worth up to $28.3 million for engineering services.
    • Volta Inc. (NYSE:VLTA) jumped 18.1% to $0.8588 after the company announced it will be acquires by Shell USA.
    • VBI Vaccines Inc. (NASDAQ:VBIV) climbed 15.8% to $0.6969.
    • Evolus, Inc. (NASDAQ:EOLS) gained 15.6% to $9.78 after the company announced preliminary unaudited Q4 and FY22 net revenue.
    • PureTech Health plc (NASDAQ:PRTC) gained 13% to $33.37.
    • Celyad Oncology SA (NASDAQ:CYAD) shares rose 12% to $2.13 after jumping 138% on Tuesday. Celyad Oncology recently issued an update on its Celyad 2.0 business strategy, which has been adopted and implemented over the last few months.
    • AVITA Medical, Inc. (NASDAQ:RCEL) rose 11.4% to $8.98 after gaining around 7% on Tuesday. AVITA Medical, last month, submitted FDA PMA application to expand indication to vitiligo.
    • Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) rose 10.6% to $1.2506. Citius Pharmaceuticals, last month, reported FY22 earnings results.
    • Moderna, Inc. (NASDAQ:MRNA) rose 8.5% to $206.99 after the company's syncytial virus vaccine candidate met its primary endpoint in a Phase 3 trial.
    • Carvana Co. (NYSE:CVNA) gained 7% to $7.82. Carvana adopted a shareholder rights plan to protect long-term shareholder value by preserving the availability of net operating loss carryforwards (NOLs) and other tax attributes under the Internal Revenue Code.


    Losers

    • Bit Brother Limited (NASDAQ:BTB) shares dipped 66.7% to $2.21 after the company reported pricing of $7.1 million registered direct offering.
    • Arcimoto, Inc. (NASDAQ:FUV) fell 59.8% to $2.21 after the company announced pricing of its $12 million public offering.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) dropped 24% to $0.45.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) shares declined 23.6% to $0.8859.
    • Greenidge Generation Holdings Inc. (NASDAQ:GREE) fell 22.6% to $0.7580.
    • Calyxt, Inc. (NASDAQ:CLXT) dropped 20.6% to $0.2805.
    • Arrival (NASDAQ:ARVL) fell 20.5% to $0.4850.
    • Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) dropped 20.3% to $5.56.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) dipped 19.7% to $1.2850. AgriFORCE and the Government of Barbados signed a MOU to collaborate on the market evaluation and development of controlled environment facilities in barbados to address nutrition and food security in the Caribbean.
    • TeraWulf Inc. (NASDAQ:WULF) dropped 19.6% to $0.8198.
    • MGO Global Inc. (NASDAQ:MGOL) fell 19.2% to $3.9562.
    • PAVmed Inc. (NASDAQ:PAVM) dipped 18% to $0.5211 after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures.
    • SOS Limited (NYSE:SOS) dropped 17.1% to $6.79.
    • Sphere 3D Corp. (NASDAQ:ANY) fell 17% to $0.38.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) dipped 16.4% to $7.01.
    • Hut 8 Mining Corp. (NASDAQ:HUT) dropped 16.4% to $1.5390.
    • Boxed, Inc. (NYSE:BOXD) fell 16.3% to $0.4909. Boxed recently announced its Spresso Saas modular solution platform is now available on Google Cloud.
    • Bright Health Group, Inc. (NYSE:BHG) dropped 13.4% to $0.9011. Bright Health Group recently announced it increased 2023 Enterprise Revenue guidance to $3.4 - $3.6 billion.
    • Chegg, Inc. (NYSE:CHGG) fell 12.2% to $21.45. Needham downgraded Chegg from Buy to Hold.
    • Riot Platforms, Inc. (NASDAQ:RIOT) dropped 11.4% to $5.68.
    • Calyxt, Inc. (NASDAQ:CLXT) fell 10.8% to $0.3151. Calyxt shares jumped over 90% on Tuesday after the company and Cibus announced a definitive merger agreement.
    • BIT Mining Limited (NYSE:BTCM) shares dropped 6.8% to $4.06. BIT Mining shares jumped 42% on Tuesday after the company announced the launch of a new energy efficient LiteCoin/DogeCoin Miner, LD3.

    Also Check This Out ReWalk Robotics, American Resources And These 2 Penny Stocks Insiders Are Aggressively Buying

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $AGRI
    $ANY
    $ARVL

    CompanyDatePrice TargetRatingAnalyst
    Avita Medical Inc.
    $RCEL
    3/5/2026$10.00Outperform
    Northland Capital
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    TeraWulf Inc.
    $WULF
    12/31/2025$24.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT, CEO, EXEC CHAIRMAN Rosensweig Daniel covered exercise/tax liability with 7,004 shares, decreasing direct ownership by 0.09% to 7,618,071 units (SEC Form 4)

    4 - CHEGG, INC (0001364954) (Issuer)

    3/13/26 9:14:27 PM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Chief Accounting Officer Reppas Tiah Norton converted options into 16,250 shares and sold $10,062 worth of shares (6,250 units at $1.61), increasing direct ownership by 419% to 12,384 units (SEC Form 4)

    4 - Sphere 3D Corp. (0001591956) (Issuer)

    3/13/26 8:22:13 PM ET
    $ANY
    Finance: Consumer Services
    Finance

    CEO and CFO Kalbfleisch Kurt L. converted options into 18,358 shares and sold $15,582 worth of shares (9,800 units at $1.59), increasing direct ownership by 15% to 64,455 units (SEC Form 4)

    4 - Sphere 3D Corp. (0001591956) (Issuer)

    3/13/26 8:00:33 PM ET
    $ANY
    Finance: Consumer Services
    Finance

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Avita Medical with a new price target

    Northland Capital initiated coverage of Avita Medical with a rating of Outperform and set a new price target of $10.00

    3/5/26 8:30:26 AM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    Morgan Stanley initiated coverage on TeraWulf with a new price target

    Morgan Stanley initiated coverage of TeraWulf with a rating of Overweight and set a new price target of $37.00

    2/9/26 7:01:58 AM ET
    $WULF
    EDP Services
    Technology

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08

    Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that on March 13, 2026 ("Grant Date"), its Compensation Committee granted equity awards pursuant to the Chegg 2023 Equity Inducement Plan (the "Plan"). One newly hired employee received a grant of restricted stock units ("RSUs") representing 150,000 shares of Chegg common stock ("Shares") in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08. The RSUs will vest over two years, with 50% of the Shares vesting after the employee has been employed for 12 months of continuous service after the Grant Date, and the remaining 50% of the Shares will vest in equal quarterly install

    3/13/26 4:30:00 PM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Carvana Board of Directors Approves 5 for 1 Forward Stock Split

    Carvana (NYSE:CVNA), the industry pioneer for buying and selling cars online, today announced that its Board of Directors approved a 5 for 1 split of its common stock. The split is designed to ensure that earning and buying whole shares of Carvana stock is within reach for all of its team members. "This is the first split in Carvana's history, and we believe it achieves the important goal of keeping our stock accessible to all of our team members," said Mark Jenkins, Chief Financial Officer of Carvana. "This decision follows significant stock appreciation as Carvana reached new all-time records for units and profitability while continuing to lead the industry in growth in 2025." Carvana

    3/13/26 9:05:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

    Conference Call and Webcast at 8:30 AM ETNEW YORK, March 12, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it will host a business update conference call and webcast on Thursday, March 26, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's fourth quarter 2025 financial results.

    3/12/26 9:01:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $30,071 worth of shares (2,085 units at $14.42), increasing direct ownership by 0.77% to 272,214 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/9/26 7:31:19 PM ET
    $WULF
    EDP Services
    Technology

    Director Ertel Thomas R bought $18,366 worth of shares (5,450 units at $3.37), increasing direct ownership by 2% to 365,788 units (SEC Form 4)

    4 - Energy Vault Holdings, Inc. (0001828536) (Issuer)

    3/5/26 11:53:24 AM ET
    $NRGV
    Industrial Machinery/Components
    Miscellaneous

    $ACHR
    $AGRI
    $ANY
    $ARVL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHR
    $AGRI
    $ANY
    $ARVL
    SEC Filings

    View All

    SEC Form 144 filed by Sphere 3D Corp.

    144 - Sphere 3D Corp. (0001591956) (Subject)

    3/13/26 4:45:09 PM ET
    $ANY
    Finance: Consumer Services
    Finance

    Evolus Inc. filed SEC Form 8-K: Leadership Update

    8-K - Evolus, Inc. (0001570562) (Filer)

    3/13/26 4:43:16 PM ET
    $EOLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Archer Aviation Inc.

    144 - Archer Aviation Inc. (0001824502) (Subject)

    3/13/26 3:57:03 PM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Leadership Updates

    Live Leadership Updates

    View All

    RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

    Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device Over 700 RenovoCath Procedures Successfully Completed Since FDA Clearance in 2014 Company Appoints Ramtin Agah, MD to the Additional Position of Executive Chairman to Support Continued Clinical Adoption and Commercial Growth MOUNTAIN VIEW, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced continued commercial progress, with

    2/27/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chegg Appoints Karine Allouche as General Manager, Language Learning, Worldwide and Skills Integration, Europe

    Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that Karine Allouche will join Busuu, Chegg's language learning business, as General Manager of Language Learning, Worldwide, and Skills Integration, Europe, effective February 9, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209423954/en/Karine Allouche In her role, Karine will focus on strengthening execution, accelerating growth, and deepening collaboration across the company, in partnership with Chegg's leadership team and the board. In addition to leading language learning, Karine will own Chegg's European commercial engine and play a key role in

    2/9/26 9:05:00 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Financials

    Live finance-specific insights

    View All

    Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

    Conference Call and Webcast at 8:30 AM ETNEW YORK, March 12, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it will host a business update conference call and webcast on Thursday, March 26, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's fourth quarter 2025 financial results.

    3/12/26 9:01:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026

    Total Net Revenue of $90.3 Million for the Fourth Quarter and $297.2 Million for the Full-Year 2025, Representing Growth of 14% and 12% Over the Prior Year Delivered GAAP Operating Income of $4.2 Million for the Fourth Quarter; Non-GAAP Operating Income of $7.1 Million for Q4 2025, Above Prior Guidance Range Full-Year GAAP Operating Expenses of $229.8 Million in 2025; Non-GAAP Operating Expense of $209.7 Million, Within the Company's Guidance Range of $208 Million to $213 Million, with Second Half 2025 Expenses Declining 4% Compared to the First Half, Driving Meaningful Year-Over-Year Operating Leverage in the Second Half 2026 Net Revenue Guidance of $327 Million to $337 Million,

    3/3/26 4:05:00 PM ET
    $EOLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Archer Announces Fourth Quarter and Full Year 2025 Results, US and UAE Air Taxi Pilot Programs On-Track for 2026

    On-track for piloted vertical take-off and landing operations as part of the White House's eVTOL Integration Pilot Program (eIPP) and Archer's UAE commercial launch program. Targeting first passenger-carrying flights in 2026.* Received final FAA acceptance of 100% of "Means of Compliance," making Archer the first to achieve this certification milestone for an eVTOL aircraft. Expanded defense opportunities with dual-use, hybrid aircraft program and powertrain sales. Ended 2025 with record liquidity of ~$2.0B. Archer Aviation Inc. ("Archer" or the "Company") (NYSE:ACHR) today announced operating and financial results for the fourth quarter and full year ended December 31, 2025

    3/2/26 4:05:00 PM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Archer Aviation Inc.

    SC 13D/A - Archer Aviation Inc. (0001824502) (Subject)

    11/18/24 9:40:14 PM ET
    $ACHR
    Aerospace
    Industrials